Some medical treatments improve slowly over decades; hepatitis C treatment underwent something closer to a revolution.
Pamela Anderson recently recalled being diagnosed with hepatitis C in 2002 and being told at the time that her future could be dramatically shortened. She eventually announced in 2015 that she had been cured. Her story spans one of modern medicine’s more remarkable transformations.
A chronic hepatitis C infection can cause cirrhosis, liver failure and liver cancer. Yet today, more than 95% of people treated with modern antiviral medications can be cured, often after just 8 to 12 weeks of pills.
Hepatitis C attacks the liver
Hepatitis C is caused by a blood-borne virus. Some people clear an acute infection naturally, but many develop chronic infection. The unsettling part is that chronic hepatitis C can remain relatively quiet for years while liver damage gradually accumulates.
People may therefore feel healthy while the virus is still causing harm.
Treatment used to be much harder
Older hepatitis C treatments often involved interferon and ribavirin. Treatment could last months, produce substantial side effects and wasn’t reliably successful. That changed with the arrival of direct-acting antiviral drugs.
The CDC says today’s oral medications cure more than 95% of patients in only 8 to 12 weeks. The agency’s clinical guidance recommends curative treatment for essentially everyone with hepatitis C. That’s an extraordinary difference from what patients faced only a couple of decades ago.
The bigger problem now is finding the infection
A cure doesn’t help someone who doesn’t know they’re infected. Hepatitis C is transmitted through exposure to infected blood. Injection drug use is a major route of transmission today, but people can have other historical exposures. Because chronic infection may not cause obvious symptoms, screening has become an important part of prevention.
Current U.S. recommendations include screening adults and screening during pregnancy, with additional testing for people with ongoing risk.
Save this article
Enter your email address and we'll send it straight to your inbox.
Being cured doesn’t mean the virus can never return
Successful treatment eliminates the existing hepatitis C infection. But it doesn’t create immunity. Someone can become infected again if they’re exposed to the virus later.
There is also currently no vaccine for hepatitis C. People who already developed advanced liver scarring before being cured may still need ongoing medical monitoring because eliminating the virus doesn’t necessarily erase damage that occurred beforehand.
The transformation has been remarkable—and incomplete
The CDC reported in 2026 that broader access to curative hepatitis C treatment could prevent enormous amounts of illness while also reducing long-term health care costs. Yet many infected people still don’t receive treatment promptly. That means the scientific problem has changed.
For years, the challenge was developing a treatment capable of reliably curing hepatitis C. Now a major challenge is making sure infected people are diagnosed and actually receive it. A diagnosis that once could mean decades of progressive liver disease can now, for most patients, end with a short course of medication and no detectable virus.
That’s the kind of medical progress that can be easy to miss when it happens gradually outside the spotlight.
Were you aware that hepatitis C is now curable in more than 95% of treated cases?
